WealthPLAN Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-67,002
Closed -$1.83M 261
2019
Q3
$1.83M Buy
67,002
+2,123
+3% +$59.6K 0.25% 83
2019
Q2
$1.97M Buy
64,879
+1,921
+3% +$60.2K 0.3% 79
2019
Q1
$1.92M Buy
62,958
+22
+0% +$635 0.3% 81
2018
Q4
$1.95M Buy
62,936
+17,089
+37% +$351K 0.31% 82
2018
Q3
$884K Buy
45,847
+7,814
+21% +$255K 0.16% 103
2018
Q2
$1.44M Buy
38,033
+29,428
+342% +$1.13M 0.29% 84
2018
Q1
$281K Buy
8,605
+3,396
+65% +$149K 0.06% 220
2017
Q4
$254K Buy
5,209
+567
+12% +$28.7K 0.07% 177
2017
Q3
$251K Buy
4,642
+896
+24% +$52.6K 0.07% 161
2017
Q2
$210K Buy
3,746
+3,616
+2,782% +$145K 0.06% 164
2017
Q1
$4.95K Buy
+130
New +$4.14K 0.02% 348
2016
Q3
$77.3K Sell
3,430
-1,330
-28% -$31.2K 0.03% 266
2016
Q2
$56.2K Buy
+4,760
New +$118K 0.01% 855

Other funds holding PTLA